Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. | SrVP/CFO/Prin Fin & Acct Ofcr | Common Stock | 18.9K | $138K | $7.29 | Mar 28, 2024 | Direct |
WINDTREE THERAPEUTICS INC /DE/ | SVP & CFO | Common Stock | 72.8K | $74.2K | $1.02 | Jul 26, 2022 | Direct |
Aprea Therapeutics, Inc. | SrVP/CFO/Prin Fin & Acct Ofcr | Stock Options (Right to Buy) | 13.5K | Mar 28, 2024 | Direct | ||
Aprea Therapeutics, Inc. | SrVP/CFO/Prin Fin & Acct Ofcr | Tranche A Warrant | 505 | Mar 13, 2024 | Direct | ||
Aprea Therapeutics, Inc. | SrVP/CFO/Prin Fin & Acct Ofcr | Tranche B Warrant | 505 | Mar 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APRE | Aprea Therapeutics, Inc. | Mar 28, 2024 | 2 | $0 | 4 | Mar 28, 2024 | SrVP/CFO/Prin Fin & Acct Ofcr |
APRE | Aprea Therapeutics, Inc. | Mar 13, 2024 | 3 | $7.36K | 4 | Mar 14, 2024 | SrVP/CFO/Prin Fin & Acct Ofcr |
APRE | Aprea Therapeutics, Inc. | Feb 27, 2023 | 1 | $5.25K | 4 | Feb 27, 2023 | SrVP/CFO/Prin Fin & Acct Ofcr |
APRE | Aprea Therapeutics, Inc. | Jan 30, 2023 | 2 | $0 | 4 | Jan 30, 2023 | SrVP/CFO/Prin. Fin&Acctg. Off |
APRE | Aprea Therapeutics, Inc. | Jan 30, 2023 | 0 | $0 | 3 | Jan 30, 2023 | SrVP/CFO/Prin. Fin &Acctg. Off |
WINT | WINDTREE THERAPEUTICS INC /DE/ | Jul 26, 2022 | 1 | $1.1K | 4 | Jul 26, 2022 | SVP & CFO |
WINT | WINDTREE THERAPEUTICS INC /DE/ | Mar 4, 2022 | 2 | $0 | 4 | Mar 7, 2022 | SVP & CFO |